Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
Símbolo de cotizaciónAIFF
Nombre de la empresaFirefly Neuroscience Inc
Fecha de salida a bolsaOct 27, 1993
Fundada en2021
Director ejecutivoMr. Greg Lipschitz
Número de empleados13
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 27
Dirección1100 Military Road
CiudadKENMORE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal14217
Teléfono18882376412
Sitio Webhttps://fireflyneuro.com/
Símbolo de cotizaciónAIFF
Fecha de salida a bolsaOct 27, 1993
Fundada en2021
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos